About: http://data.cimple.eu/news-article/3a890a8f53e7630c81f2e2294bea29daa3b1ace38b4d8ed5e9f139a0

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/3a890a8f53e7630c81f2e2294bea29daa3b1ace38b4d8ed5e9f139a0 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Russia has reached out to German biotechnology company IDT Biologika to explore jointly producing the Sputnik V coronavirus vaccine, the German health ministry said Wednesday. It comes a day after The Lancet journal published trial results showing the Sputnik vaccine to be 91.6 percent effective against Covid-19, defying international scepticism about the Russian-made jab. A German health ministry spokeswoman told AFP that Russia's state-run Gamaleya research institute, which developed Sputnik V, and the Russian Direct Investment Fund (RDIF), which helped finance the project, "are interested in a co-partner for a possible production and have as such contacted IDT Biologika". "The contents or details of confidential discussions are not known," she added. IDT, based in Dessau in eastern Germany, declined to comment when contacted by AFP. The positive data from the Sputnik trial come as the European Union faces growing impatience over its vaccination rollout, which has been dogged by delivery delays and supply shortages. German Chancellor Angela Merkel on Tuesday said "all vaccines" are welcome in the EU so long as they have been approved by the European Medicines Agency (EMA). Merkel already spoke with Russian President Vladimir Putin last month about the Sputnik jab, offering the help of Germany's Paul Ehrlich Institute in assisting Russia with the application process for the EMA. "And if this vaccine is approved by the EMA, then we can talk about joint production or also about usage," Merkel said at the time. German firm IDT is itself working on a Covid-19 vaccine, but early trial results have not been encouraging. Like fellow German vaccine makers BioNTech and CureVac, IDT has received state support to fund its coronavirus research, to the tune of 114 million euros ($140 million). mfp/hmn/spm
schema:headline	Russia has asked Germany's IDT about making Sputnik vaccine: ministry
schema:mentions	Paul Ehrlich Institute Biotechnology Chancellor of Germany Agence France-Presse European Medicines Agency Sputnik 1 The Lancet Jab Angela Merkel President of Russia Germany European Union Russia Vladimir Putin Vaccine United States Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Dessau Integrated Device Technology Russian Direct Investment Fund CureVac
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-02-03 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	82 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software